Investors sold shares of Humana Inc (NYSE:HUM) on strength during trading on Wednesday. $40.22 million flowed into the stock on the tick-up and $69.39 million flowed out of the stock on the tick-down, for a money net flow of $29.17 million out of the stock. Of all equities tracked, Humana had the 26th highest net out-flow for the day. Humana traded up $0.52 for the day and closed at $270.50
HUM has been the topic of a number of research analyst reports. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $294.00 price objective on the stock in a research report on Monday, February 12th. Jefferies Group raised shares of Humana from a “hold” rating to a “buy” rating and set a $221.00 price objective on the stock in a research report on Friday, January 12th. Goldman Sachs Group initiated coverage on shares of Humana in a research report on Wednesday, January 3rd. They set a “buy” rating and a $305.00 price objective on the stock. Cowen reaffirmed a “buy” rating and set a $285.00 price objective on shares of Humana in a research report on Wednesday, December 13th. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and set a $250.00 price objective on shares of Humana in a research report on Wednesday, February 7th. Eight equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $270.47.
The company has a debt-to-equity ratio of 0.48, a current ratio of 1.85 and a quick ratio of 1.85. The firm has a market capitalization of $36,928.31, a P/E ratio of 16.22, a price-to-earnings-growth ratio of 1.46 and a beta of 0.95.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, March 30th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.74%. This is a boost from Humana’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend is Wednesday, March 28th. Humana’s payout ratio is presently 9.59%.
Humana announced that its Board of Directors has authorized a share buyback program on Thursday, December 14th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the insurance provider to repurchase shares of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s management believes its shares are undervalued.
In other news, insider M Todoroff Christopher sold 16,389 shares of the business’s stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $273.37, for a total value of $4,480,260.93. Following the completion of the sale, the insider now directly owns 13,447 shares in the company, valued at $3,676,006.39. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Cynthia H. Zipperle sold 1,196 shares of the business’s stock in a transaction on Friday, March 9th. The stock was sold at an average price of $273.33, for a total transaction of $326,902.68. Following the completion of the sale, the senior vice president now owns 7,771 shares of the company’s stock, valued at $2,124,047.43. The disclosure for this sale can be found here. Insiders sold 41,775 shares of company stock valued at $11,169,845 over the last 90 days. 0.60% of the stock is owned by corporate insiders.
Institutional investors have recently modified their holdings of the company. Certified Advisory Corp acquired a new stake in shares of Humana in the fourth quarter worth $109,000. Fieldpoint Private Securities LLC acquired a new position in Humana during the 3rd quarter valued at $115,000. American Beacon Advisors Inc. acquired a new position in Humana during the 4th quarter valued at $122,000. ClariVest Asset Management LLC acquired a new position in Humana during the 3rd quarter valued at $144,000. Finally, YorkBridge Wealth Partners LLC raised its stake in Humana by 99.0% during the 4th quarter. YorkBridge Wealth Partners LLC now owns 597 shares of the insurance provider’s stock valued at $159,000 after purchasing an additional 297 shares during the last quarter. Institutional investors and hedge funds own 97.85% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This story was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://sportsperspectives.com/2018/03/14/investors-sell-humana-hum-on-strength-hum.html.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.